Net Income

In a major strategic coup, Barnes & Thornburg acquires an elite 12-lawyer insurance group, creating a national powerhouse and shaking up the legal market.

A hidden danger in IV lines causes thousands of preventable deaths. Now, one company is showcasing a new strategy to protect patients from this 'gross gap'.

The diagnostics firm posts strong 2025 growth, but the impending loss of a key partner puts its high-stakes strategic pivot squarely to the test.

IM Cannabis has 180 days to raise its stock price above $1.00 or risk delisting from Nasdaq, highlighting broader struggles in the global cannabis sector.

The deal with Sample Healthcare signals a major shift from managing data to using AI to execute revenue cycle tasks, tackling costs and staffing shortages.

Lead Real Estate’s ENT TERRACE hotels secure prestigious Booking.com awards, reflecting a successful strategy in Japan's booming extended-stay market.

As pet owners seek unique items, advanced laser engravers are empowering a new wave of entrepreneurs to tap into a multi-billion dollar market.

Amaero's major titanium powder agreement signals a massive production boost, aiming to strengthen the US supply chain for defense and aerospace industries.

The passing of Gordon Bowerman, Yangarra's chairman for over two decades, leaves a legacy of growth and a critical question of succession for the company.

Following a $600M all-stock acquisition, security firm Concorde International embraces a new identity, YOOV, signaling a bold pivot into AI.

Orvana Minerals targets European investors at key conferences as it navigates widening losses and seeks to capitalize on strong commodity markets.

Mazda names Continental Battery Systems its nationwide partner, a strategic move to streamline dealer supply and enhance service in the growing aftermarket.

The Chinese EV maker released landmark ESG and climate reports, boosting transparency as it navigates tough regulations and mixed investor sentiment.

Rebellions, SK Telecom, and Arm unite to build independent AI infrastructure, challenging Silicon Valley's dominance with energy-efficient technology.

A new partnership between a Chinese biotech and a Brazilian public institute aims to slash the $500k cost of CAR-T therapy, making it accessible to all.

With a massive $54M Series A, Vivatides Therapeutics aims to solve RNA's biggest delivery problem, unlocking new treatments for a host of chronic diseases.

A new report shows the Middle East conflict has triggered a three-year high in supply chain pressure, leading to soaring costs, shortages, and stockpiling.

A new report reveals a startling paradox in retail trading: high win rates don't equal profits, as traders pull capital and struggle with gold markets.

As NW Natural Holdings sets its Q1 2026 earnings call, investors watch to see if its diversification strategy can sustain last year's record growth.

Long after headlines fade, a relief organization is expanding its mission to rebuild homes and lives devastated by Hurricane Helene across four states.